- Home
- TXMD vs TNON Comparison
TXMD vs TNON Comparison
Compare TXMD & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- TNON
- Stock Information
- Founded
- TXMD 2008
- TNON 2012
- Country
- TXMD United States
- TNON United States
- Employees
- TXMD N/A
- TNON N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- TXMD Health Care
- TNON Health Care
- Exchange
- TXMD Nasdaq
- TNON Nasdaq
- Market Cap
- TXMD 12.7M
- TNON 11.5M
- IPO Year
- TXMD N/A
- TNON 2022
- Fundamental
- Price
- TXMD $1.06
- TNON $1.17
- Analyst Decision
- TXMD
- TNON Strong Buy
- Analyst Count
- TXMD 0
- TNON 2
- Target Price
- TXMD N/A
- TNON $5.50
- AVG Volume (30 Days)
- TXMD 17.5K
- TNON 269.5K
- Earning Date
- TXMD 11-11-2025
- TNON 11-12-2025
- Dividend Yield
- TXMD N/A
- TNON N/A
- EPS Growth
- TXMD N/A
- TNON N/A
- EPS
- TXMD N/A
- TNON N/A
- Revenue
- TXMD $2,559,000.00
- TNON $2,947,000.00
- Revenue This Year
- TXMD $427.09
- TNON $43.52
- Revenue Next Year
- TXMD N/A
- TNON $82.14
- P/E Ratio
- TXMD N/A
- TNON N/A
- Revenue Growth
- TXMD 156.93
- TNON N/A
- 52 Week Low
- TXMD $0.70
- TNON $0.85
- 52 Week High
- TXMD $2.44
- TNON $7.51
- Technical
- Relative Strength Index (RSI)
- TXMD 40.43
- TNON 44.55
- Support Level
- TXMD $1.06
- TNON $1.13
- Resistance Level
- TXMD $1.14
- TNON $1.26
- Average True Range (ATR)
- TXMD 0.05
- TNON 0.07
- MACD
- TXMD -0.00
- TNON -0.01
- Stochastic Oscillator
- TXMD 5.26
- TNON 26.09
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.